28% A global leader in contract packaging and clinical trial supply services to the pharmaceucal and healthcare industries of H1 2018 Operang Profit Commercial contract packaging services - In mulple formats including biotech, boling, blistering and specialty Clinical trial services - from pre-clinical through to commercialisaon including clinical contract packaging services and Interacve Response Technology (IRT) Packaging design, labelling and prinng soluons and industry-leading serialisaon soluons Key Market Trends - Connued demand for outsourced sevices, growth of speciality drugs, growth of digital soluons including ‘Track and Trace’ compliance (required for prescripon drugs to have a unique serial code to combat counterfit drugs) UD G H ea l t hc a r e pl c UDG Healthcare is a leading internaonal partner of choice delivering advisory, communicaon, commercial, clinical and packaging services to the healthcare industry. UDG Healthcare enables and supports large pharmaceucal to small biotech companies to bring their products to market, ensuring paents can access these drugs and providing support to educate healthcare professionals and paents on these products. The company provides outsourced services to over 300 healthcare companies at all stages of the drug life cycle, including sales reps, nurse-led training, healthcare communicaons and packaging. Our divisions TOP 30 pharma companies are all clients FTSE 250 listed 3 operang divisions 30-year+ dividend growth 9,000 employees 24 countries Acquisions completed since the United Drug disposal in April 2016 Proceeds from disposal of United drug Supply Chain businesses reinvested in high-growth businesses, to expand the range of capabilies UDG offers global pharmaceucal base 4% A leading expert and provider of outsourced services to the medical and scienfic sector of H1 2018 Operang Profit 68% A global leader in advisory, communicaon, commercial and clinical services for the pharmaceucal and healthcare industries of H1 2018 Operang Profit Advisory - Healthcare brand advisory, consulng and commercial audit services Communicaons - Scienfic communicaon content, behavioral change strategies, digital and creave paent- centre services Commercial & Clinical - Commercialisaon and clinical services including sales representaves, nursing services, contact centres and meengs and events Key Market Trends - Growth of specialty drugs resulng in increased demand for mulchannel and digital comms; increasing drug approvals; migraon to direct paent engagement, growth in orphan drug & rare diseases, medicine pricing pressure Medical and scienfic device sales, markeng, engineering and distribuon in endoscopy, cardiology, radiology and surgical Group Geographic Revenue Split: • North America • UK • Rest of World / Other 19% 24% 57% Total acquision consideraon of up to $75.8m Q2 FY16 Q1 FY17 Q3 FY17 Q4 FY17 Total acquision consideraon of up to £16.8m Total acquision consideraon of up to £84m Total acquision consideraon of up to $14.4m Total acquision consideraon of up to $35m Acquision of pharmaceucal packaging facility, total consideraon of $14m Total acquision consideraon of up to $32m